Video

Educated Patient® Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session: November 13, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session on demand.

Related Videos
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman wearing a red tank top.
Image of Annie Bond.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Image of a man with brown hair.
Image of a woman with short brown hair and glasses.
Image of a woman with short brown hair and glasses.
Image of a man with brown hair and a suit and tie.
Related Content
Illustration of woman with short brown hair.
October 9th 2024

Being Unprepared May Open The Door To Life-Changing Lessons With Stage 4 Cancer

Martha Carlson
Martha Carlson shares her experience of overcoming her fears and embarking on a whitewater rafting adventure despite her stage 4 cancer diagnosis.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illuatration of large intesines inside body.
October 5th 2024

Non-Surgical Options May Maintain Relapse-Free Survival in Rectal Cancer Subset

Ariana Pelosci
Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
"FDA" text.
October 3rd 2024

FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer

Darlene Dobkowski, MA
The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic HER2-low or -ultralow breast cancer.
Illustration of lungs.
October 3rd 2024

Perioperative Opdivo Extends Event-Free Survival in Lung Cancer

Kyle Doherty
Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.